Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Ion Source

By Drug Discovery Trends Editor | June 3, 2009

ProsoliaProsolia, Inc. introduces an advanced Omni Spray Ion Source model based on the desorption electrospray ionization (DESI) technology. The Omni Spray 2-D Ion Source has an automated surface platform that enables rapid sampling and surface imaging. The platform can handle samples up to 76 mm by 114 mm, which is the size of a standard 96-well micro-titer plate.

The Omni Spray 2-D Ion Source achieves a step resolution down to 50µm and has an open access sample stage that fits up to three standard Omni Slides or an Omni Slide – HC. A new feature of the Omni Spray 2-D Ion Source allows for angle adjustment of DESI spray head without changing other geometrical parameters for quick optimization. The 2-D Ion Source is software controlled with an intuitive graphical user interface. The new Omni Spray 2-D Ion Source is easy to install and remove, allowing for rapid turnaround when switching to another ion source. Highlights of the 2-D Source includes the ability to perform surface imaging experiments at atmospheric pressure such as the direct analysis, tissue samples, or even thin layer chromatography (TLC) plates. The 2-D Source is also able to analyze 96 sample spots in less than ten minutes.

www.prosolia.com

Published in Drug Discovery & Development magazine: Vol. 12, No. 6, June, 2009, p. 6-7.


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE